DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Monahan PE, Walsh CE, Powell JS. , et al.
Update on the phase 1/2 trial of BAX-335, an adeno-associated virus 8 (AAV8) vector-based gene therapy for program for hemophilia B.
J Thromb Haemost 2015;
13 (Suppl. 02) 87
We do not assume any responsibility for the contents of the web pages of other providers.